Table of Contents

Articles

• 

  You have access

  Structural Basis for the Allosteric Inhibition of Hypoxia-Inducible Factor 2 by Belzutifan

  Xintong Ren, Xiaotong Diao, Jingjing Zhuang and Dalei Wu

  Molecular Pharmacology December 2022, 102 (6) 240-247; DOI: https://doi.org/10.1124/molpharm.122.000525
• You have access

  Cancer-Type Organic Anion Transporting Polypeptide 1B3 Is Localized in Lysosomes and Mediates Resistance against Kinase Inhibitors

  Bastian Haberkorn, Stefan Oswald, Niklas Kehl, Arne Gessner, R. Verena Taudte, Jan Philipp Dobert, Friederike Zunke, Martin F. Fromm and Jörg König

  Molecular Pharmacology December 2022, 102 (6) 248-258; DOI: https://doi.org/10.1124/molpharm.122.000539
• You have access

  Differential Enantiomer-Specific Signaling of Cannabidiol at CB₁ Receptors

  Taryn Bosquez-Berger, Sierra Wilson, Christos Iliopoulos-Tsoutsouvas, Shan Jiang, Jim Wager-Miller, Spyros P. Nikas, Ken P. Mackie, Alexandros Makriyannis and Alex Straiker

  Molecular Pharmacology December 2022, 102 (6) 259-268; DOI: https://doi.org/10.1124/molpharm.121.000305
• 

  You have access

  Coincident Regulation of PLCβ Signaling by Gq-Coupled and μ-Opioid Receptors Opposes Opioid-Mediated Antinociception

  Gissell A. Sanchez, Emily M. Jutkiewicz, Susan Ingram and Alan V. Smrcka

  Molecular Pharmacology December 2022, 102 (6) 269-279; DOI: https://doi.org/10.1124/molpharm.122.000541